Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC.
Simiene J, Dabkeviciene D, Stanciute D, Prokarenkaite R, Jablonskiene V, Askinis R, Normantaite K, Cicenas S, Suziedelis K.
Simiene J, et al. Among authors: dabkeviciene d.
BMC Cancer. 2023 Sep 12;23(1):857. doi: 10.1186/s12885-023-11365-5.
BMC Cancer. 2023.
PMID: 37697308
Free PMC article.